In vivo somatic mutations in humans: measurement and analysis.

INTROD UCTION . . . . . . . . ... . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ... . . . . . . . . . . . . . . . . . . . 306 THE CELL S yS TEMS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 306 Red Blood Cells . . . . . .. . . . . . . . . . . . . . . . . . . .... . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . ... . . .. . . . . ... . . . . .. . . 306 T-Lymphocytes . . . . .. . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 307 THE GENETIC SyS TEMS . . . . . . . .. . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 308 Genes Scored in Red Cells . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . 308 Genes Sco re d in T-lymphoc ytes . . . . . . . . . . . . . . . . . . . . . . ... . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . .. . .... . . 308 THE AS SAyS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 309 HbS 309 GPA .... . . . . . . . ...... . . . . . . . . ..... . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ....... . ... . . ... . . . . . . . . . . . . . . ... . . . 309 hprt . .. . . . . . . . . . . .. . . . . . . . . . . . . .... . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ...... . . . . . . . . . . . . . . . . . . . . ..... . . 310 HLA .. . . . . . . . . . . ... . . . . . . . . . . .. ... . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . ... . . . . . . . . . . . . . . . . .. . . .. . . . . 310 QUANTITATIVE MEAS UREMENTS OF Vf OR Mf IN H UMAN SOMATIC CELLS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 1 1 HbS 312 GPA . . . . . . . . . .. . . . . . . . . . . . . . . . . ... . . . . . . . . . . .. . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 312 hprt . . . . . . . . . . . . .. . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . .. . . . . . . . ..... . . . . . ... . . . . . . . . .. . . . . . . . . . . . . . . . . . .. . . . 313 HLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 314 RELATIONSHIPS BETWEEN MEAS URED M UTANT FREQUENCIES AND PROB AB LE M UTATION FREQUENCIES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 314 MOLEC ULAR ANALYSES OF IN VIVO SOM ATIC M UTATION S IN H UMANS. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 315 hpr t Mutations... . . . . . . . . . . . . . . . . . . . . . . . . . . . ... . . . . . . . . .. . . . . . . .. . . . . . . . . . . . . . . . . . . . . . ... . . . . . . . . . . 315 HLA Mutations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 319 CONCLUS IONS. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 319

[1]  L. B. Russell,et al.  Radiation-Induced Presumed Somatic Mutations in the House Mouse. , 1957, Genetics.

[2]  G. Stamatoyannopoulos,et al.  F-cells in the adult: normal values and levels in individuals with hereditary and acquired elevations of Hb F. , 1975, Blood.

[3]  G. Stamatoyannopoulos,et al.  A new form of hereditary persistence of fetal hemoglobin in blacks and its association with sickle cell trait. , 1975, Blood.

[4]  J. Lawrence,et al.  Localization of the human α-globin structural gene to chromosome 16 in somatic cell hybrids by molecular hybridization assay , 1977, Cell.

[5]  R. Albertini,et al.  T-cell cloning to detect the mutant 6-thioguanine-resistant lymphocytes present in human peripheral blood. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[6]  R. Albertini,et al.  15 – 6-THIOGUANINE-RESISTANT LYMPHOCYTES IN HUMAN BLOOD , 1984 .

[7]  D. Ledbetter,et al.  Organization of the HPRT gene and related sequences in the human genome , 1984, Somatic cell and molecular genetics.

[8]  Kevin J. Trainor,et al.  Mutation frequency in human lymphocytes increases with age , 1984, Mechanisms of Ageing and Development.

[9]  K. Messing,et al.  In vivo mutant frequency rises among breast cancer patients after exposure to high doses of gamma-radiation. , 1985, Mutation research.

[10]  P. Nowell,et al.  Location of gene for beta subunit of human T-cell receptor at band 7q35, a region prone to rearrangements in T cells. , 1985, Science.

[11]  T. Waldmann,et al.  Human γ-chain genes are rearranged in leukaemic T cells and map to the short arm of chromosome 7 , 1985, Nature.

[12]  R. Albertini Somatic gene mutations in vivo as indicated by the 6-thioguanine-resistant T-lymphocytes in human blood. , 1985, Mutation research.

[13]  A. Morley,et al.  Methods for study of mutations and mutagenesis in human lymphocytes. , 1985, Mutation research.

[14]  B. Davidson,et al.  A molecular survey of hypoxanthine-guanine phosphoribosyltransferase deficiency in man. , 1986, The Journal of clinical investigation.

[15]  K. Messing,et al.  In vivo mutant frequency of technicians professionally exposed to ionizing radiation. , 1986, Progress in clinical and biological research.

[16]  K. Messing,et al.  Molecular characterization of 15 rearrangements among 90 human in vivo somatic mutants shows that deletions predominate , 1987, Molecular and cellular biology.

[17]  R. Albertini,et al.  Molecular analyses of in vivo hprt mutations in human T-lymphocytes. I. Studies of low frequency 'spontaneous' mutants by Southern blots. , 1987, Mutagenesis.

[18]  R. Tice,et al.  The use of bromodeoxyuridine labeling in the human lymphocyte HGPRT somatic mutation assay. , 1987, Mutation research.

[19]  R. Albertini,et al.  Refinement of a T-lymphocyte cloning assay to quantify the in vivo thioguanine-resistant mutant frequency in humans. , 1987, Mutagenesis.

[20]  M. Green,et al.  A further assessment of factors influencing measurements of thioguanine-resistant mutant frequency in circulating T-lymphocytes. , 1988, Mutation research.

[21]  A. Morley,et al.  Karyotypic abnormality of the X chromosome is rare in mutant HPRT-lymphocyte clones. , 1988, Mutation research.

[22]  A. Morley,et al.  Mutations in human lymphocytes commonly involve gene duplication and resemble those seen in cancer cels. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[23]  R. Albertini,et al.  Mutagenicity monitoring in humans by autoradiographic assay for mutant T lymphocytes. , 1988, Mutation research.

[24]  A. Morley,et al.  Mutations in human lymphocytes studied by an HLA selection system. , 1988, Mutation research.

[25]  B. Davidson,et al.  Identification of a single nucleotide change in the hypoxanthine-guanine phosphoribosyltransferase gene (HPRTYale) responsible for Lesch-Nyhan syndrome. , 1989, The Journal of clinical investigation.

[26]  S. Kudo,et al.  Structural organization of glycophorin A and B genes: glycophorin B gene evolved by homologous recombination at Alu repeat sequences. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[27]  B. Lambert,et al.  Hprt mutations and karyotype abnormalities in T-cell clones from healthy subjects and melphalan-treated ovarian carcinoma patients. , 1989, Mutation research.

[28]  W. Bigbee,et al.  Evidence for an elevated frequency of in vivo somatic cell mutations in ataxia telangiectasia. , 1989, American journal of human genetics.

[29]  A. Morley,et al.  The HLA-A mutation assay: improved technique and normal results. , 1989, Mutation research.

[30]  W. Bigbee,et al.  Evidence for increased in vivo mutation and somatic recombination in Bloom's syndrome. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[31]  R. Albertini,et al.  Longitudinal study of the in vivo hprt mutant frequency in human T‐lymphocytes as determined by a cell cloning assay , 1989, Environmental and molecular mutagenesis.

[32]  M. Akiyama,et al.  Detection of somatic mutations at the glycophorin A locus in erythrocytes of atomic bomb survivors using a single beam flow sorter. , 1989, Cancer research.

[33]  M. Akiyama,et al.  Molecular analyses of in vivo hprt mutant T cells from atomic bomb survivors , 1989, Environmental and molecular mutagenesis.

[34]  A. Tates,et al.  Detection of somatic mutants in man: HPRT mutations in lymphocytes and hemoglobin mutations in erythrocytes. , 1989, Mutation research.

[35]  6-Thioguanine resistant T-lymphocyte determination as a possible indicator of human ionizing radiation exposure. , 1989, Boletin de estudios medicos y biologicos.

[36]  B. Davidson,et al.  Molecular basis of hypoxanthine-guanine phosphoribosyltransferase deficiency in ten subjects determined by direct sequencing of amplified transcripts. , 1989, The Journal of clinical investigation.

[37]  W. Bigbee,et al.  Flow cytometric analysis of erythrocyte populations in Tn syndrome blood using monoclonal antibodies to glycophorin A and the Tn antigen. , 1990, Cytometry.

[38]  A. Tates,et al.  Mutations affecting RNA splicing in man are detected more frequently in somatic than in germ cells. , 1990, Mutation research.

[39]  R. Albertini,et al.  Molecular analysis of in vivo hprt mutations in human T lymphocytes. V. Effects of total body irradiation secondary to radioimmunoglobulin therapy (RIT) , 1990, Mutagenesis.

[40]  T. Skopek,et al.  DNA sequence analysis of in vivo hprt mutation in human T lymphocytes. , 1990, Mutagenesis.

[41]  J. Schöneich,et al.  Increased frequency of 6-thioguanine-resistant lymphocytes in peripheral blood of workers employed in cyclophosphamide production. , 1990, Mutation research.

[42]  A. Wyrobek,et al.  The effect of chemotherapy on the in vivo frequency of glycophorin A 'null' variant erythrocytes. , 1990, Mutation research.